141 related articles for article (PubMed ID: 35965499)
21. Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
Front Oncol; 2021; 11():587479. PubMed ID: 33868990
[TBL] [Abstract][Full Text] [Related]
22. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
23. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
[TBL] [Abstract][Full Text] [Related]
24.
Gao Y; Li Y; Song Z; Jin Z; Li X; Yuan C
J Oncol; 2022; 2022():6509028. PubMed ID: 35847356
[TBL] [Abstract][Full Text] [Related]
25. SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma.
Zhang X; Zhang H; Liao Z; Zhang J; Liang H; Wang W; Yu J; Dong K
Cancer Cell Int; 2022 Jan; 22(1):24. PubMed ID: 35033067
[TBL] [Abstract][Full Text] [Related]
26. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression.
Yu Y; Chen X; Zhang W; Liu J
Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303
[TBL] [Abstract][Full Text] [Related]
27. Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Li D; Cheng X; Zheng W; Chen J
Cancer Manag Res; 2020; 12():4923-4935. PubMed ID: 32606980
[TBL] [Abstract][Full Text] [Related]
28.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
29. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
30. Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma.
Fan Y; Hou J; Liu X; Han B; Meng Y; Liu B; Chen F; Shang Y; Cao P; Tan K
Front Genet; 2021; 12():668516. PubMed ID: 34917120
[TBL] [Abstract][Full Text] [Related]
31. KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway.
Jiang S; Zhang Y; Li Q; Qiu L; Bian B
Onco Targets Ther; 2020; 13():5657-5668. PubMed ID: 32606779
[TBL] [Abstract][Full Text] [Related]
32. DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data.
Zhu C; Tong R; Jiang X; Xiao H; Guan J; Shu J
Front Genet; 2021; 12():767834. PubMed ID: 35265097
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
34. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.
Ouyang X; Lv L; Zhao Y; Zhang F; Hu Q; Li Z; Zhu D; Li L
Front Oncol; 2021; 11():801506. PubMed ID: 35087760
[TBL] [Abstract][Full Text] [Related]
35. Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway.
Zhang Y; Qin P; Xu X; Li M; Huang H; Yan J; Zhou Y
Front Oncol; 2021; 11():792285. PubMed ID: 35047403
[TBL] [Abstract][Full Text] [Related]
36. LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis.
Zhong F; Liu S; Hu D; Chen L
J Cancer; 2022; 13(3):1048-1060. PubMed ID: 35154469
[No Abstract] [Full Text] [Related]
37. Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
Zhu C; Xiao H; Jiang X; Tong R; Guan J
Front Genet; 2021; 12():819520. PubMed ID: 35173766
[No Abstract] [Full Text] [Related]
38. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
39. Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Hu X; Bao M; Huang J; Zhou L; Zheng S
Front Oncol; 2020; 10():541479. PubMed ID: 33102213
[No Abstract] [Full Text] [Related]
40. Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.
Xu W; Lu X; Liu J; Chen Q; Huang X; Huang K; Liu H; Zhu W; Zhang X
Front Oncol; 2021; 11():700700. PubMed ID: 34490100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
